Прогноз развития гестационных осложнений у женщин с алиментарно-конституционнальным типом ожирения

Обложка

Цитировать

Полный текст

Аннотация

В данном обзоре проведен анализ отечественных и зарубежных литературных источников по исследованию механизма развития и диагностики осложнений у беременных с ожирением.

Об авторах

Ольга Вячеславовна Аршинова

Российский университет дружбы народов

Email: olgaarhsinova@gmail.com

Ольга Алексеевна Кузнецова

Российский университет дружбы народов

Татьяна Викторовна Смирнова

Российский университет дружбы народов

Email: olgaarhsinova@gmail.com

Список литературы

  2. Atzeni I. et al. Placental growth factor (PLGF): correlations with placental function. Int. J. Gyn. Obst. 2012. Vol.119 (Suppl.3). P.782-783.
  3. Banoo E., Sharifi F., Badamchizadeh Z. et al. Association of metabolic syndrome with inflammatory mediators in women with previous gestational diabetes mellitus. J. Diabetes Metab Disord. 2013.
  4. Dedov I.I., Shestakova M.V., Aleksandrov A.A. Algorithms of specialized medical care to patients with diabetes. Diabetes mellitus. 2011. No. 5.
  5. Dubovoy A. Prospects for studying biomarkers predictor of preeclampsia and its complications. Young scientist Bulletin. 2012. No. 1.
  6. Heerwagen M.J., Miller M.R., Barbour L.A. et al. Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010. Vol. 299. Iss. 3. P. 711-722.
  7. Hromylev A.V. Metabolic syndrome and pregnancy. Obesity and Metabolism. 2014. No. 2. P. 3-7.
  8. Kozyreva E.V., Davidian L.Y. Role of growth factors in the pathogenesis of infertility and miscarriage. Modern problems of science and education. 2015. No. 4. P. 444.
  9. Igitova M.B., Dmitrienko G.V. Prediction of adverse perinatal outcomes-based growth factor placenta. Mother and Child in the Kuzbass. 2014. No. 4, Iss. 59.
  10. Ignatko I.V., Shcherbakova G., Miryuschenko M. Prognozirovanie perinatal complications in pregnant women with overweight and obesity. Journal of International Research Journal of R. 2014. Vol. 8. Iss. 3[27]. P. 25.
  11. Litvinova L.C., Kirienkova E.V., Gazatova N.D. et al. Features cytokine ability of peripheral blood mononuclear cells of patients with metabolic syndrome. Cytokines & inflammation. 2013. No. 3. P. 1.
  12. Lumeng C.N., Saltiel A.R. Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 2011. Vol. 121. Iss. 6. P. 2111-2117.
  13. Makarov I.O., Borovkov E.I., Abramov M.Yu. The course of pregnancy and childbirth in women with obesity. Journal of Obstetrics, Gynecology and reproduction. 2011. Vol. 5. P. 27.
  14. Muona K. Safety of VEGF gene therapy in cardiovasculardiseases. Dissertations in Health Sciences. Publications of the University of Eastern Finland (Department of Biotechnology and Molecular Medicine). 2013.
  15. Miehle K., Holger S., Fasshauer M. et al. Adiponectin and other Adipokines in Gestational Diabetes Mellitus and Pre-eclampsia. Clin. Endocrinol. 2012. Vol. 76. Iss. 1. P. 2-11.
  16. Misra V.K., Trudeau S. The Influence of Overweight and Obesity on Longitudinal Trends in Maternal Serum Leptin Levels During Pregnancy. Obesity. 2011. Vol. 192. P. 416-421.
  17. Obstetrics: National guide. 2nd edition revised and enlarged. Ed. by G.M. Savelieva, G.T. Sukhikh, V.N. Serov, V.E. Radzinsky. GEOTAR-Media. 2015.
  18. Peredereeva E.V. Hormone Leptin and reproduction problems. Malignant tumors Magazine. 2012. Vol. 2. Iss. 1. P. 1-5.
  19. Petunina N.A., Cousin I.A. Role hormones adipose tissue in the development of complications of pregnancy in obese women. Obesity and Metabolism. 2013. Vol. 1 P. 3-8.
  20. Qiu C., Williams M.A., Vadachkoria S. et al. Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstetrics and Gynecology. 2004. Vol. 103. P. 519-525.
  21. Chalid M. The dynamics of angiogenic factors, endothelial and placental dysfunction in maternal plasma and placental expression of early and late onset preeclampsia; possibility of combining the classification diagnosis and the onset of preeclampcia based on angiogenic factors. Int. J. Gyn. 2012. Vol. 119 (Suppl. 3). P. 308.
  22. Samolis S., Papastefanou I., Panagopoulos P. et al. Relation between first trimester maternal serum leptin levels and body mass index in normotensive and pre-eclamptic pregnancies - role of leptin as a marker of pre-eclampsia: a prospective case-control study. Gynecological Endocrinology. 2010. No. 26. P. 338-343.
  23. Walsh J.M., McGowan C.A., Byrne J.A. The association between TNF-a and insulin resistance in euglycemic women. Cytokine. 2013. Vol. 64. Iss. 1. P. 208-212.

© Аршинова О.В., Кузнецова О.А., Смирнова Т.В., 2016

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution 4.0 International License.

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах